The impact of gender on the efficacy of immune checkpoint inhibitors in cancer patients: the MOUSEION-01 study

M Santoni, A Rizzo, V Mollica, MR Matrana… - Critical Reviews in …, 2022 - Elsevier
The primary endpoint of MOUSEION-01 was to assess overall survival (OS) in male and
female patients receiving immune checkpoint inhibitors versus control treatments …
被引用次数：126 相关文章

The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study

M Santoni, A Rizzo, V Mollica, MR Matrana… - CRITICAL REVIEWS IN …, 2022 - cris.unibo.it
The primary endpoint of MOUSEION-01 was to assess overall survival (OS) in male and
female patients receiving immune checkpoint inhibitors versus control treatments …

The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.

M Santoni, A Rizzo, V Mollica, MR Matrana… - Critical Reviews in …, 2022 - europepmc.org
The primary endpoint of MOUSEION-01 was to assess overall survival (OS) in male and
female patients receiving immune checkpoint inhibitors versus control treatments …

The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study

M Santoni, A Rizzo, V Mollica… - Critical reviews in …, 2022 - pubmed.ncbi.nlm.nih.gov
The primary endpoint of MOUSEION-01 was to assess overall survival (OS) in male and
female patients receiving immune checkpoint inhibitors versus control treatments …